Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44,542,200
-
Total 13F shares
-
9,752,756
-
Share change
-
+7,412
-
Total reported value
-
$161,293,000
-
Price per share
-
$16.54
-
Number of holders
-
43
-
Value change
-
+$2,115,721
-
Number of buys
-
22
-
Number of sells
-
26
Institutional Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q3 2020
As of 30 Sep 2020,
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,752,756 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Essex Woodlands Management, Inc., RTW INVESTMENTS, LP, Alyeska Investment Group, L.P., VANGUARD GROUP INC, COWEN AND COMPANY, LLC, Opaleye Management Inc., SILVERCREST ASSET MANAGEMENT GROUP LLC, BlackRock Inc., and PURA VIDA INVESTMENTS, LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.